Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Opus Genetics, Inc. | 2,015,797 | reported | 20 Apr 2026 | tx 25+3,155,979−1,574 |
| Zentalis Pharmaceuticals, Inc. | 633,680 | reported | 31 May 2024 | tx 149+1,387,811−534,409 |
| QUIKBYTE SOFTWARE INC | 35,000 | reported | 23 Jan 2014 | tx 3+419,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Apr 2026 | GRANT_AWARD | Opus Genetics, Inc. | 24,367 | 0.00 USD | |
| 06 Jan 2026 | GRANT_AWARD | Opus Genetics, Inc. | 67,000 | 0.00 USD | |
| 29 Dec 2025 | PURCHASE | Opus Genetics, Inc. | 81,000 | 1.98 USD | first after silence |
| 31 Dec 2025 | GRANT_AWARD | Opus Genetics, Inc. | 33,000 | 0.00 USD | |
| 29 Dec 2025 | PURCHASE | Opus Genetics, Inc. | 83,000 | 1.97 USD | |
| 25 Aug 2025 | GRANT_AWARD | Opus Genetics, Inc. | 869,565 | 1.15 USD | |
| 30 Apr 2025 | GRANT_AWARD | Opus Genetics, Inc. | 79,504 | 0.00 USD | |
| 30 Apr 2025 | GRANT_AWARD | Opus Genetics, Inc. | 79,592 | 0.00 USD | deriv |
| 24 Mar 2025 | GRANT_AWARD | Opus Genetics, Inc. | 784,314 | — | |
| 24 Mar 2025 | GRANT_AWARD | Opus Genetics, Inc. | 784,314 | — | deriv |
| 11 Jun 2024 | GRANT_AWARD | Opus Genetics, Inc. | 41,143 | 0.00 USD | |
| 11 Jun 2024 | GRANT_AWARD | Opus Genetics, Inc. | 35,181 | 0.00 USD | deriv |
| 31 May 2024 | SALE | Zentalis Pharmaceuticals, Inc. | 9,597 | 11.98 USD | |
| 12 Feb 2024 | SALE | Zentalis Pharmaceuticals, Inc. | 1,173 | 11.44 USD | |
| 02 Feb 2024 | SALE | Zentalis Pharmaceuticals, Inc. | 11,552 | 11.54 USD | |
| 01 Feb 2024 | GRANT_AWARD | Zentalis Pharmaceuticals, Inc. | 192,500 | 0.00 USD | |
| 01 Feb 2024 | GRANT_AWARD | Zentalis Pharmaceuticals, Inc. | 192,500 | 0.00 USD | deriv |
| 06 Jun 2023 | GRANT_AWARD | Opus Genetics, Inc. | 10,976 | 0.00 USD | |
| 06 Jun 2023 | GRANT_AWARD | Opus Genetics, Inc. | 9,639 | 0.00 USD | deriv |
| 31 May 2023 | SALE | Zentalis Pharmaceuticals, Inc. | 9,242 | 26.40 USD | |
| 31 May 2023 | SALE | Zentalis Pharmaceuticals, Inc. | 18,526 | 26.21 USD | |
| 13 Feb 2023 | SALE | Zentalis Pharmaceuticals, Inc. | 3,332 | 20.42 USD | |
| 14 Feb 2023 | SALE | Zentalis Pharmaceuticals, Inc. | 8,501 | 19.96 USD | |
| 06 Feb 2023 | SALE | Zentalis Pharmaceuticals, Inc. | 572 | 23.04 USD | |
| 06 Feb 2023 | SALE | Zentalis Pharmaceuticals, Inc. | 9,428 | 22.22 USD |
1 purchase reported after at least 12 months of silence — most recent on 29 Dec 2025.